Condition
Urothelial Carcinoma of the Renal Pelvis and Ureter clinical trials and research
Research outlook What's coming for Bladder cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 5 Urothelial Carcinoma of the Renal Pelvis and Ureter clinical trials that are recruiting, at sites in 5 countries (most in China (1), Japan (1), Canada (1)). By phase: Phase 2 (2), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 5Countries
Newest Urothelial Carcinoma of the Renal Pelvis and Ureter clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Combination treatment for advanced urothelial carcinoma | Phase 2 | Nagoya, Aichi-ken | Recruiting | May 21, 2025 |
| Comparing two treatments for advanced urothelial carcinoma | Phase 2 | Changsha, Hunan and 1 other locations | Recruiting | Feb 12, 2025 |
| European validation of Bladder EpiCheck for haematuria | — | Dunfermline, Fife and 4 other locations | Recruiting | Feb 10, 2025 |
| Using ST-02 to treat low-grade upper tract urothelial carcinoma | Phase 2/3 | Vancouver, British Columbia and 7 other locations | Recruiting | Nov 9, 2023 |
| Registry of patients with upper tract urothelial cancer treated with Jelmyto | — | Santa Monica, California and 21 other locations | Recruiting | May 25, 2023 |
All recruiting trials (5)
-
Combination treatment for advanced urothelial carcinoma
This study is testing a new combination of a drug called AM80 with standard chemotherapy and immunotherapy to see if it helps people with advanced bladder cancer feel better and live longer.
-
Comparing two treatments for advanced urothelial carcinoma
This study is testing if a combination of two treatments can help people with advanced bladder cancer do better than using just one of the treatments alone.
-
European validation of Bladder EpiCheck for haematuria
This project will see if the Bladder EpiCheck urine methylation test can detect urothelial cancer in people aged 45 and older who have visible or non-visible blood in their urine.
-
Using ST-02 to treat low-grade upper tract urothelial carcinoma
This study is testing a new treatment called ST-02 to see if it can safely help people with low-grade upper tract urothelial carcinoma feel better after receiving weekly treatments for six weeks.
-
Registry of patients with upper tract urothelial cancer treated with Jelmyto
This study is looking at how well Jelmyto works for people with upper tract urothelial cancer by tracking their experiences and outcomes over time.
Related topics
Quick answers
How many Urothelial Carcinoma of the Renal Pelvis and Ureter clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in China (1 trial), Japan (1 trial), Canada (1 trial), United Kingdom (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.